Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SZ-05 for Depression and Anxiety
NCT03323697Phase 2Unknown
- Sponsor
- Mazra Mental Health Center
- Start
- Aug 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SZ-05 in major depressive disorder (MDD), anxiety disorder, sponsored by Mazra Mental Health Center. Status: unknown.
02
Drugs
SZ-05
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on NCT03323697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03323697.